ImmunityBio, Inc. (IBRX)
6.015
-0.06
(-0.91%)
USD |
NASDAQ |
Nov 13, 16:00
6.02
0.00 (0.00%)
After-Hours: 19:59
ImmunityBio Market Cap : 6.399B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 6.457B |
| November 11, 2026 | 7.095B |
| November 10, 2026 | 7.175B |
| November 09, 2026 | 7.563B |
| November 06, 2026 | 9.186B |
| November 05, 2026 | 8.521B |
| November 04, 2026 | 9.405B |
| November 03, 2026 | 8.731B |
| November 02, 2026 | 8.373B |
| October 30, 2026 | 8.731B |
| October 29, 2026 | 9.205B |
| October 28, 2026 | 9.279B |
| October 27, 2026 | 9.089B |
| October 26, 2026 | 8.226B |
| October 23, 2026 | 8.657B |
| October 22, 2026 | 8.752B |
| October 21, 2026 | 9.100B |
| October 20, 2026 | 9.237B |
| October 19, 2026 | 8.868B |
| October 16, 2026 | 9.669B |
| October 15, 2026 | 10.53B |
| October 14, 2026 | 10.44B |
| October 13, 2026 | 10.32B |
| October 12, 2026 | 10.66B |
| October 09, 2026 | 11.07B |
| Date | Value |
|---|---|
| October 08, 2026 | 10.44B |
| October 07, 2026 | 10.27B |
| October 06, 2026 | 10.21B |
| October 05, 2026 | 10.93B |
| October 02, 2026 | 10.83B |
| October 01, 2026 | 9.774B |
| September 30, 2026 | 9.942B |
| September 29, 2026 | 9.300B |
| September 28, 2026 | 8.973B |
| September 25, 2026 | 8.889B |
| September 24, 2026 | 9.100B |
| September 23, 2026 | 9.089B |
| September 22, 2026 | 9.784B |
| September 21, 2026 | 8.900B |
| September 18, 2026 | 8.931B |
| September 17, 2026 | 8.910B |
| September 16, 2026 | 8.331B |
| September 15, 2026 | 8.573B |
| September 14, 2026 | 8.815B |
| September 11, 2026 | 8.331B |
| September 10, 2026 | 8.131B |
| September 09, 2026 | 8.489B |
| September 08, 2026 | 8.731B |
| September 04, 2026 | 8.510B |
| September 03, 2026 | 8.626B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 90.17B |
| Sarepta Therapeutics, Inc. | 1.722B |
| Arrowhead Pharmaceuticals, Inc. | 6.741B |
| Oncolytics Biotech, Inc. | 46.07M |
| Sangamo Therapeutics, Inc. | 45.57M |
Market Cap Related Metrics
| PS Ratio | 33.99 |
| PEG Ratio | -0.0362 |
| Price | 6.015 |
| Earnings Yield | -17.83% |
| PEGY Ratio | -0.0362 |